QRG Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Buy
11,302
+951
+9% +$353K 0.04% 326
2026
Q1
$3.03M Sell
10,351
-1,037
-9% -$341K 0.03% 348
2025
Q4
$3.99M Buy
11,388
+1,191
+12% +$402K 0.04% 290
2025
Q3
$3.29M Sell
10,197
-27,614
-73% -$8.59M 0.04% 303
2025
Q2
$14.7M Sell
37,811
-38,150
-50% -$15.3M 0.13% 167
2025
Q1
$33M Buy
75,961
+15,148
+25% +$6.08M 0.34% 62
2024
Q4
$22.4M Sell
60,813
-21,580
-26% -$9.03M 0.23% 87
2024
Q3
$42.8M Buy
82,393
+1,318
+2% +$704K 0.46% 36
2024
Q2
$43.9M Buy
81,075
+2,166
+3% +$1.14M 0.52% 36
2024
Q1
$40.9M Buy
78,909
+17,714
+29% +$8.81M 0.52% 39
2023
Q4
$28.9M Buy
61,195
+5,065
+9% +$2.34M 0.43% 47
2023
Q3
$24.4M Buy
+56,130
New +$25.5M 0.42% 48

Other funds holding ELV

QRG Capital Management's ELV Position: Q2 2026 in Review

QRG Capital Management increased its Elevance Health (ELV) stake by 9.2% in Q2 2026, buying an estimated $353K and bringing the position to 11,302 shares worth $4.37M. The position accounts for 0.04% of the portfolio, ranked #326.

QRG Capital Management first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $43.9M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • QRG Capital Management held 11,302 shares of Elevance Health worth $4.37M as of Q2 2026.
  • QRG Capital Management bought 951 Elevance Health shares in Q2 2026, an estimated $353K.
  • Elevance Health made up 0.04% of QRG Capital Management's portfolio in Q2 2026, its #326 holding.
  • QRG Capital Management first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Elevance Health position peaked at $43.9M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.